A critical role for murine complement regulator crry in fetomaternal tolerance.
暂无分享,去创建一个
B. Palanca | V. Holers | A. Cheng | H. Molina | B. Palanca | Chenguang Xu | C. Xu | D. Mao
[1] H. Colten,et al. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. , 1999, Immunopharmacology.
[2] John D Lambris,et al. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Okabe,et al. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. , 1998, The Biochemical journal.
[4] R. Karr,et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Hourcade,et al. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein , 1995, The Journal of experimental medicine.
[6] M. Dehoff,et al. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. , 1993, Journal of immunology.
[7] C. Holmes,et al. Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship. , 1992, Bailliere's clinical obstetrics and gynaecology.
[8] W. D. Billington,et al. 2 The normal fetomaternal immune relationship , 1992 .
[9] J. Bulmer,et al. Immune aspects of pathology of the placental bed contributing to pregnancy pathology. , 1992, Bailliere's clinical obstetrics and gynaecology.
[10] V. Holers,et al. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1 , 1992, The Journal of experimental medicine.
[11] M. Rudnicki,et al. Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.
[12] M. Daha,et al. Decreased expression of decay-accelerating factor on endothelial cells of immune complex-mediated vasculitic skin lesions. , 1991, Journal of dermatological science.
[13] M. Nose,et al. Expression of decay‐accelerating factor is reduced on hyperplastic synovial lining cells in rheumatoid synovitis , 1991, Clinical and experimental immunology.
[14] M. Tanner,et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. , 1990, Journal of immunology.
[15] M. Aegerter,et al. Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry. , 1989, Journal of immunology.
[16] D. Fearon,et al. p65: A C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. , 1985, Journal of immunology.
[17] J. Atkinson,et al. Complement in human reproduction: Activation and control , 1993, Immunologic research.
[18] V. Holers,et al. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. , 1992, Immunology today.
[19] J. Atkinson,et al. Decay-accelerating factor and membrane cofactor protein. , 1990, Current topics in microbiology and immunology.
[20] D. Hourcade,et al. The Regulators of Complement Activation (RCA) Gene Cluster , 1989 .